[Optimization of strategy of surgical treatment for acute destructive pancreatitis].
Results of surgical treatment of 142 patients with acute destructive pancreatitis were analyzed. The treatment of patients was divided into two periods. The first period included 59 (41.5%) patients when active surgical strategy was used. The second period of observations included 83 (53.5%) patients with the optimized strategy of treatment based on intensive therapy, prognosis of the course of the disease, new antibacterial medicines and new technologies of operative treatment. A comparison of the results of treatment has revealed the advantages of using the optimized strategy and allowed the postoperative lethality to be reduced from 59.3 to 32.5%.
M M
MM
Vinokurov
V G
VG
Ammosov
V V
VV
Ignat'ev
D000208:Acute Disease; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D024841:Fluoroquinolones / Q000627:therapeutic use; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D000077731:Meropenem; D015282:Octreotide / Q000627:therapeutic use; D010180:Pancreatectomy; D010195:Pancreatitis / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000401:mortality / Q000601:surgery*; D011183:Postoperative Complications; D011300:Preoperative Care; D011379:Prognosis; D012307:Risk Factors; D013845:Thienamycins / Q000627:therapeutic use; D013997:Time Factors; D014463:Ultrasonography
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D024841:Fluoroquinolones; D005765:Gastrointestinal Agents; D013845:Thienamycins; D000077731:Meropenem; D015282:Octreotide